Pharmaceutical Business Review
Anonymous User | Login

Actavis Divests Norgesplaster

Published: 01-Feb-2010

Actavis has sold Norgesplaster, its manufacturing facility for plasters and athletic tape and adhesive coating, in Vennesla, Norway, to a newly formed entity, Norgesplaster AS. Norgesplaster AS is a legal entity owned by private Norwegian investors. The transaction covers all assets and contracts related to Norgesplaster.

Actavis became the owner of Norgesplaster in December 2005, following the acquisition of the generics division of Alpharma. Actavis' focus remains on its core business, generic pharmaceuticals. Actavis will continue to operate a sales and marketing office in Oslo for pharmaceutical products.

Norgesplaster is Norway's supplier of plasters and medical grade anchored products. Actavis and Norgesplaster AS will work together to ensure that there will be no disruption in supply or services. Current employees will continue to be employed by Norgesplaster.

The transaction was closed on 29 January 2010, but will have financial effect from 1 January 2010. The financial details of the transaction were not disclosed.

Mail sent successfully

Tell your friend about this article


Please enter a valid email address

Please enter your name

Please enter the mail body


Your Name: *
Your Email: *
Friend's Email: *
Email Body: *
 

Suppliers To This Sector

Browse A-Z

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Valsynthese

Hazardous Chemistry in Safe Hands ...

USB

Products from Affymetrix ...

Umicore Precious Metals Chemistry

Chemicals and Catalysts for Industrial Applications ...

Thomson Reuters

The World's Leading Source of Life Sciences Intelligent Information ...

TAPI

A Leading Global Supplier of Active Pharmaceutical Ingredients ...

Pharma IQ

Workshops, Conferences and Training Courses for Pharmaceutical Professionals ...

White Papers

Browse A-Z

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Your IP at Risk in Collaborations!

Free white paper: Ten steps to protect your R&D investment within partnerships. ...

Why, When and How to Conduct 14C Human Studies

Several risk-based strategies to assess metabolites exist. Whatever the strategy chosen, t ...

Why CAPA Still Matters

This free white paper explores the needs and effectiveness of correct CAPA control, how to ...

Water Treatment

From the control room to the downstream processing area and with an eye on utilities servi ...

Using the Mean Kinetic Temperature (MKT) As a Parameter to Determine Whether Perishable Goods Have Been Transported and Stored Correctly

Tecnosoft systems use MKT calculation to control the acquired values and report the user w ...

USB HotStart-IT for Real Time PCR

USBĀ® Products from Affymetrix have a long-standing reputation in the life science marketpl ...

Related Companies

Barr Pharmaceuticals, Inc.

Barr Pharmaceuticals, Inc. (Barr) is engaged in the development, manufacturing and mark ...

Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries Limited (Teva), a global pharmaceutical company, is enga ...

Actavis Group hf.

Actavis Group hf. (Actavis) is a pharmaceutical company engaged in the development, man ...

Suppliers Product News

Accovion Selects Liquent Insight Publisher

Contract Research Organization Chooses Thomson Reuters Software Solution

Thomson Reuters Makes Disease Briefing on Influenza Covering H1N1 (Swine Flu) Publicly Available

Free Access Given to Support the Global R&D and Healthcare Community

Thomson Reuters Announces the Availabilty of Three Pharma Matters Reports Covering January - March 2009

Quarterly Reports Use Market Intelligence and Competitive Analysis from Thomson Reuters to Highlight Developments in the Global Pharmaceutical Industry

Free Newsletter Sign-up

Sign up, and we will send you a free Pharmaceutical report on “ Combination Products – Evolution of the Medical Equipment Industry” from GlobalData worth $750

Please enter a valid email address